Mitochondrial Therapeutics for Cardioprotection

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|20|2017-2035

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.20, 2011-01, pp. : 2017-2035

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trends in Mitochondrial Therapeutics for Neurological Disease

By  

Current Medicinal Chemistry, Vol. 22, Iss. 20, 2015-01 ,pp. : 2458-2467

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Mitochondrial Membrane Permeability as a Putative Pharmacological Target for Cardioprotection

By  

Current Medicinal Chemistry, Vol. 16, Iss. 33, 2009-11 ,pp. : 4382-4398

Bentham Science Publishers

Access to resources Recommend Favorite

Erythropoietin (EPO) Affords More Potent Cardioprotection by Activation of Distinct Signaling to Mitochondrial Kinases Compared with Carbamylated EPO

By Sato Takahiro   Tanno Masaya   Miki Takayuki   Yano Toshiyuki   Sato Tatsuya   Shimamoto Kazuaki   Miura Tetsuji  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 5-6, 2010-12 ,pp. : 401-408

Springer Publishing Company

Access to resources Recommend Favorite

A Novel Danshensu-Tetramethylpyrazine Conjugate DT-018 Provides Cardioprotection by Preserving Mitochondrial Function Through the MEF2D/PGC-1α Pathway

By  

Current Pharmaceutical Design, Vol. 23, Iss. 39, 2018-02 ,pp. : 6062-6070

Bentham Science Publishers

Access to resources Recommend Favorite

Kinins and Cardioprotection

By Wirth K.J.   Linz W.   Wiemer G.   Scholkens B.A.  

Pharmacological Research, Vol. 35, Iss. 6, 1997-06 ,pp. : 527-530

Academic Press

Access to resources Recommend Favorite